Rebecca A. Redman, M.D.

Rebecca A. Redman, M.D.

Rebecca A. Redman, M.D.

UofL Health - Brown Cancer Center
529 South Jackson Street
Louisville, KY 40202

502-852-2522 - Academic Office
502-562-4370 - Patient Appointments

Clinical Expertise
Medical Oncology; Hematology; Gastrointestinal Cancers; Head and Neck Cancers

Board Certifications

  • American Board of Internal Medicine -
    Medical Oncology / Hematology

Education and Training

  • Medical School: University of Wisconsin
  • Residency: University of North Carolina Hospitals
  • Fellowship: Duke University

Featured Publications

  • Harrington KJ, Ferris RL, Gillison M, Tahara M, Argiris A, Fayette J, Schenker M, Bratland Å, Walker JWT, Grell P, Even C, Chung CH, Redman R, Coutte A, Salas S, Grant C, de Azevedo S, Soulières D, Hansen AR, Wei L, Khan TA, Miller-Moslin K, Roberts M, Haddad R. Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical Trial. JAMA Oncol. 2023 Jun 1;9(6):779-789. doi: 10.1001/jamaoncol.2023.0147. PMID: 37022706; PMCID: PMC10080406.
  • Jorgensen J, Redman R, Jusufbegovic M. The Ethics of Palliative Surgery for Locally Advanced Head and Neck Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2023 May 20. doi: 10.1002/ohn.378. Epub ahead of print. PMID: 37210609.
  • Johnson L, Ha DT, Hall MB, Shoemaker G, Bevins PA, Strickley J, Demehri S, Redman RA, Joh J. Trending Anti-E7 Serology Predicts Mortality and Recurrence of HPV-Associated Cancers of the Oropharynx. J Oncol. 2022 Sep 26;2022:3107990. doi: 10.1155/2022/3107990. PMID: 36199787; PMCID: PMC9529406.
  • Maharaj S, Chang S, Kloecker G, Chesney J, Redman R, Rojan A. Venous and arterial thromboembolism with immunotherapy compared to platinum-based therapy. Thromb Res. 2022 Sep;217:48-51. doi: 10.1016/j.thromres.2022.07.006. Epub 2022 Jul 14. PMID: 35853370.
  • Maharaj S, Seegobin K, Wakeman K, Chang S, Potts K, Williams B, Redman R. Sinonasal renal cell-like adenocarcinoma arising in von Hippel Lindau (VHL) syndrome. Oral Oncol. 2022 Feb;125:105705. doi: 10.1016/j.oraloncology.2021.105705. Epub 2022 Jan 5. PMID: 34998175.
  • Yap TA, Vieito M, Baldini C, Sepúlveda-Sánchez JM, Kondo S, Simonelli M, Cosman R, van der Westhuizen A, Atkinson V, Carpentier AF, Löhr M, Redman R, Mason W, Cervantes A, Le Rhun E, Ochsenreither S, Warren L, Zhao Y, Callies S, Estrem ST, Man M, Gandhi L, Avsar E, Melisi D. First-In-Human Phase I Study of a Next-Generation, Oral, TGFβ Receptor 1 Inhibitor, LY3200882, in Patients with Advanced Cancer. Clin Cancer Res. 2021 Dec 15;27(24):6666-6676. doi: 10.1158/1078-0432.CCR-21-1504. Epub 2021 Sep 21. PMID: 34548321; PMCID: PMC9414273.
  • Khanal S, Strickley JD, Ha T, Demehri S, Ghim SJ, Jenson AB, Redman RA, Joh JJ. Human papillomavirus-positivity is associated with EREG down-regulation and promoter hypermethylation in head and neck squamous cell carcinoma. Exp Mol Pathol. 2020 Dec;117:104549. doi: 10.1016/j.yexmp.2020.104549. Epub 2020 Sep 30. PMID: 33007298.
  • Bhandari S, Kumar R, Tripathi P, Chan A, Mudra S, Redman R. Correction to: Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis. Med Oncol. 2019 Nov 1;36(12):100. doi: 10.1007/s12032-019-1319-4. Erratum for: Med Oncol. 2019 Sep 16;36(10):90. PMID: 31673861.
  • Bhandari S, Kumar R, Tripathi P, Chan A, Mudra S, Redman R. Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis. Med Oncol. 2019 Sep 16;36(10):90. doi: 10.1007/s12032-019-1315-8. Erratum in: Med Oncol. 2019 Nov 1;36(12):100. PMID: 31529163.
  • Tamura K, Tsurutani J, Takahashi S, Iwata H, Krop IE, Redfern C, Sagara Y, Doi T, Park H, Murthy RK, Redman RA, Jikoh T, Lee C, Sugihara M, Shahidi J, Yver A, Modi S. Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study. Lancet Oncol. 2019 Jun;20(6):816-826. doi: 10.1016/S1470-2045(19)30097-X. Epub 2019 Apr 29. Erratum in: Lancet Oncol. 2019 May 10;: PMID: 31047803.